Phase 3 ACC Clinical Trials

38 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 120 of 38 trials

Recruiting
Phase 2Phase 3

Naltrexone for Overdose Prevention

Overdose Accidental
University of California, San Francisco100 enrolled1 locationNCT06633900
Recruiting
Phase 3

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

Opioid UseTobacco UsePolysubstance Abuse
Rutgers, The State University of New Jersey420 enrolled2 locationsNCT06033599
Recruiting
Phase 2Phase 3

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Mucopolysaccharidosis IIIMPS IIIASanfilippo Syndrome+1 more
Ultragenyx Pharmaceutical Inc36 enrolled5 locationsNCT02716246
Recruiting
Phase 3

A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

Varicella (Chickenpox)Chickenpox Vaccine
GC Biopharma Corp474 enrolled1 locationNCT07054099
Recruiting
Phase 3

Shingrix in Renal Transplant Recipients

Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Phase 3

Cannabis-Tobacco Co-Use Treatment Study

Tobacco Use DisorderTobacco Use CessationCannabis Use+2 more
Medical University of South Carolina200 enrolled1 locationNCT06883162
Recruiting
Phase 2Phase 3

Study of Cannabidiol in Sanfilippo Syndrome

Mucopolysaccharidosis IIISanfilippo Syndrome
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center35 enrolled1 locationNCT06333041
Recruiting
Phase 2Phase 3

Minocycline in Stroke Study at Maimonides

Cerebrovascular Accident (Stroke)StrokeMortality+4 more
Joyce Chen1,164 enrolled1 locationNCT07237048
Recruiting
Phase 3

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination

Pneumococcal Vaccines
Vaxcyte, Inc.720 enrolled30 locationsNCT07425392
Recruiting
Phase 3

Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation

Tobacco Dependence
University of Alabama at Birmingham400 enrolled1 locationNCT03912194
Recruiting
Phase 3

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Low-grade GliomaRapidly Accelerated Fibrosarcoma (RAF) Altered GliomaPediatric Low-grade Glioma
Day One Biopharmaceuticals, Inc.400 enrolled138 locationsNCT05566795
Recruiting
Phase 3

Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus

Cholera Vaccination
International Vaccine Institute2,824 enrolled5 locationsNCT07304284
Recruiting
Phase 3

Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease

Tobacco SmokingAlcohol-Related Disorders
VA Office of Research and Development270 enrolled1 locationNCT07039175
Recruiting
Phase 3

Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

VaccinationInfluenza (Pandemic)Avian Influenza
University Health Network, Toronto120 enrolled1 locationNCT07240558
Recruiting
Phase 3

RSV Vaccine in Transplant Recipients

Immune SuppressionVaccine Response ImpairedRespiratory Syncytial Virus Infections
University Health Network, Toronto100 enrolled1 locationNCT06593210
Recruiting
Phase 3

CAR-T Long Term Follow Up (LTFU) Study

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals1,400 enrolled118 locationsNCT02445222
Recruiting
Phase 3

A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years

Enterovirus 71 Inactivated Vaccine
Medigen Vaccine Biologics Corp.378 enrolled3 locationsNCT07178522
Recruiting
Phase 3

Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma

Perennial Allergic Rhinitis Accompanied by Asthma
Daewon Pharmaceutical Co., Ltd.274 enrolled1 locationNCT07168473
Recruiting
Phase 3

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

SafetyVaccinationChildren+3 more
Jean-Pierre Van geertruyden344 enrolled1 locationNCT06844487
Recruiting
Phase 2Phase 3

A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)

Mucopolysaccharidosis II
Denali Therapeutics Inc.63 enrolled32 locationsNCT05371613